Editors' note: Variability in reported physician practices for brain death determination
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Variability in reported physician practices for brain death determination,” Braksick et al. reported that a survey of physicians at 3 academic medical centers demonstrated variability in performance of brain death evaluations. For example, many respondents reported that they perform ancillary tests for indications outside those described in the 2010 AAN Practice Parameter, including institutional mandates, protection from liability, and following the observation that a patient breathes during apnea testing. In their comments, Sethi and Machado reinforce their finding that ancillary tests are often ordered for indications outside the AAN Practice Parameter recommendations and note that it is imperative to remember that (1) brain death is a clinical determination and (2) ancillary tests can have both false positives and false negatives. Machado also suggests that the AAN criteria be revised to require an ancillary test to reduce variability in brain death policies. Braksick et al. disagree with this proposal, noting that the value of ancillary tests is “extremely questionable.” Furthermore, with respect to Machado's argument that implementing universal mandatory ancillary testing would reduce variability in brain death policies, in light of the fact that he also noted that only 6.5% of policies mandate ancillary testing, it would clearly be more reasonable for these policies to change to conform to the current AAN Practice Parameter than for the other 93.5% of protocols to start mandating ancillary testing. To reinforce awareness about the indications for ancillary testing, Braksick et al. advocate for formal education about brain death determination for all clinicians performing brain death evaluations. They, unfortunately, found that 76% of respondents did not receive formal training on performance of this evaluation. Accordingly, to decrease variability in brain death determination, the Neurocritical Care Society has recently released a training module on brain death.1 Machado further comments that he recently proposed a new disorder of consciousness, based on the case of Jahi McMath, which exists when a patient meets clinical criteria for brain death but has ancillary tests that conflict with the clinical findings. Further discussion of this interesting case and the questions it generated can be found elsewhere.2
In “Variability in reported physician practices for brain death determination,” Braksick et al. reported that a survey of physicians at 3 academic medical centers demonstrated variability in performance of brain death evaluations. For example, many respondents reported that they perform ancillary tests for indications outside those described in the 2010 AAN Practice Parameter, including institutional mandates, protection from liability, and following the observation that a patient breathes during apnea testing. In their comments, Sethi and Machado reinforce their finding that ancillary tests are often ordered for indications outside the AAN Practice Parameter recommendations and note that it is imperative to remember that (1) brain death is a clinical determination and (2) ancillary tests can have both false positives and false negatives. Machado also suggests that the AAN criteria be revised to require an ancillary test to reduce variability in brain death policies. Braksick et al. disagree with this proposal, noting that the value of ancillary tests is “extremely questionable.” Furthermore, with respect to Machado's argument that implementing universal mandatory ancillary testing would reduce variability in brain death policies, in light of the fact that he also noted that only 6.5% of policies mandate ancillary testing, it would clearly be more reasonable for these policies to change to conform to the current AAN Practice Parameter than for the other 93.5% of protocols to start mandating ancillary testing. To reinforce awareness about the indications for ancillary testing, Braksick et al. advocate for formal education about brain death determination for all clinicians performing brain death evaluations. They, unfortunately, found that 76% of respondents did not receive formal training on performance of this evaluation. Accordingly, to decrease variability in brain death determination, the Neurocritical Care Society has recently released a training module on brain death.1 Machado further comments that he recently proposed a new disorder of consciousness, based on the case of Jahi McMath, which exists when a patient meets clinical criteria for brain death but has ancillary tests that conflict with the clinical findings. Further discussion of this interesting case and the questions it generated can be found elsewhere.2
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Alert Me
Recommended articles
-
Commentary
Practice Current: When do you order ancillary tests to determine brain death?Nathaniel M. Robbins, James L. Bernat et al.Neurology: Clinical Practice, May 23, 2018 -
Special Article
Evidence-based guideline update: Determining brain death in adultsReport of the Quality Standards Subcommittee of the American Academy of NeurologyEelco F.M. Wijdicks, Panayiotis N. Varelas, Gary S. Gronseth et al.Neurology, June 07, 2010 -
Contemporary Issues
An interdisciplinary response to contemporary concerns about brain death determinationAriane Lewis, James L. Bernat, Sandralee Blosser et al.Neurology, January 31, 2018 -
Article
Variability in reported physician practices for brain death determinationSherri A. Braksick, Christopher P. Robinson, Gary S. Gronseth et al.Neurology, January 25, 2019